Global Drugs for Schistosomiasis Market Growth 2021-2026
According to this latest study, the 2021 growth of Drugs for Schistosomiasis will have significant change from previous year. By the most conservative estimates of global Drugs for Schistosomiasis market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 77 million in 2020. Over the next five years the Drugs for Schistosomiasis market will register a 3.9% CAGR in terms of revenue, the global market size will reach US$ 90 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for Schistosomiasis market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Praziquantel
Oxamniquine
Other
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drugs for Schistosomiasis Consumption 2016-2026
2.1.2 Drugs for Schistosomiasis Consumption CAGR by Region
2.2 Drugs for Schistosomiasis Segment by Type
2.2.1 Praziquantel
2.2.2 Oxamniquine
2.2.3 Other
2.3 Drugs for Schistosomiasis Sales by Type
2.3.1 Global Drugs for Schistosomiasis Sales Market Share by Type (2016-2021)
2.3.2 Global Drugs for Schistosomiasis Revenue and Market Share by Type (2016-2021)
2.3.3 Global Drugs for Schistosomiasis Sale Price by Type (2016-2021)
2.4 Drugs for Schistosomiasis Segment by Application
2.4.1 S. haematobium
2.4.2 S. mansoni
2.4.3 S. japonicum
2.4.4 S. mekongi
2.4.5 S. intercalatum
2.5 Drugs for Schistosomiasis Sales by Application
2.5.1 Global Drugs for Schistosomiasis Sale Market Share by Application (2016-2021)
2.5.2 Global Drugs for Schistosomiasis Revenue and Market Share by Application (2016-2021)
2.5.3 Global Drugs for Schistosomiasis Sale Price by Application (2016-2021)
3 Global Drugs for Schistosomiasis by Company
3.1 Global Drugs for Schistosomiasis Sales Market Share by Company
3.1.1 Global Drugs for Schistosomiasis Sales by Company (2019-2021)
3.1.2 Global Drugs for Schistosomiasis Sales Market Share by Company (2019-2021)
3.2 Global Drugs for Schistosomiasis Revenue Market Share by Company
3.2.1 Global Drugs for Schistosomiasis Revenue by Company (2019-2021)
3.2.2 Global Drugs for Schistosomiasis Revenue Market Share by Company (2019-2021)
3.3 Global Drugs for Schistosomiasis Sale Price by Company
3.4 Global Manufacturers Drugs for Schistosomiasis Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drugs for Schistosomiasis Product Location Distribution
3.4.2 Players Drugs for Schistosomiasis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Drugs for Schistosomiasis by Region
4.1 Global Drugs for Schistosomiasis by Region
4.1.1 Global Drugs for Schistosomiasis Sales by Region
4.1.2 Global Drugs for Schistosomiasis Revenue by Region
4.2 Americas Drugs for Schistosomiasis Sales Growth
4.3 APAC Drugs for Schistosomiasis Sales Growth
4.4 Europe Drugs for Schistosomiasis Sales Growth
4.5 Middle East & Africa Drugs for Schistosomiasis Sales Growth
5 Americas
5.1 Americas Drugs for Schistosomiasis Sales by Country
5.1.1 Americas Drugs for Schistosomiasis Sales by Country (2016-2021)
5.1.2 Americas Drugs for Schistosomiasis Revenue by Country (2016-2021)
5.2 Americas Drugs for Schistosomiasis Sales by Type
5.3 Americas Drugs for Schistosomiasis Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drugs for Schistosomiasis Sales by Region
6.1.1 APAC Drugs for Schistosomiasis Sales by Region (2016-2021)
6.1.2 APAC Drugs for Schistosomiasis Revenue by Region (2016-2021)
6.2 APAC Drugs for Schistosomiasis Sales by Type
6.3 APAC Drugs for Schistosomiasis Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drugs for Schistosomiasis by Country
7.1.1 Europe Drugs for Schistosomiasis Sales by Country (2016-2021)
7.1.2 Europe Drugs for Schistosomiasis Revenue by Country (2016-2021)
7.2 Europe Drugs for Schistosomiasis Sales by Type
7.3 Europe Drugs for Schistosomiasis Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drugs for Schistosomiasis by Country
8.1.1 Middle East & Africa Drugs for Schistosomiasis Sales by Country (2016-2021)
8.1.2 Middle East & Africa Drugs for Schistosomiasis Revenue by Country (2016-2021)
8.2 Middle East & Africa Drugs for Schistosomiasis Sales by Type
8.3 Middle East & Africa Drugs for Schistosomiasis Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Drugs for Schistosomiasis Distributors
10.3 Drugs for Schistosomiasis Customer
11 Global Drugs for Schistosomiasis Market Forecast
11.1 Global Drugs for Schistosomiasis Forecast by Region
11.1.1 Global Drugs for Schistosomiasis Forecast by Regions (2021-2026)
11.2.2 Global Drugs for Schistosomiasis Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Drugs for Schistosomiasis Forecast by Type
11.7 Global Drugs for Schistosomiasis Forecast by Application
12 Key Players Analysis
12.1 Shin Poong
12.1.1 Shin Poong Company Information
12.1.2 Shin Poong Drugs for Schistosomiasis Product Offered
12.1.3 Shin Poong Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Shin Poong Main Business Overview
12.1.5 Shin Poong Latest Developments
12.2 Merck
12.2.1 Merck Company Information
12.2.2 Merck Drugs for Schistosomiasis Product Offered
12.2.3 Merck Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Merck Main Business Overview
12.2.5 Merck Latest Developments
12.3 Bayer
12.3.1 Bayer Company Information
12.3.2 Bayer Drugs for Schistosomiasis Product Offered
12.3.3 Bayer Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Bayer Main Business Overview
12.3.5 Bayer Latest Developments
12.4 EIPICO
12.4.1 EIPICO Company Information
12.4.2 EIPICO Drugs for Schistosomiasis Product Offered
12.4.3 EIPICO Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 EIPICO Main Business Overview
12.4.5 EIPICO Latest Developments
12.5 Chandra Bhagat Pharma
12.5.1 Chandra Bhagat Pharma Company Information
12.5.2 Chandra Bhagat Pharma Drugs for Schistosomiasis Product Offered
12.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Chandra Bhagat Pharma Main Business Overview
12.5.5 Chandra Bhagat Pharma Latest Developments
12.6 Taj Pharmaceuticals
12.6.1 Taj Pharmaceuticals Company Information
12.6.2 Taj Pharmaceuticals Drugs for Schistosomiasis Product Offered
12.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Taj Pharmaceuticals Main Business Overview
12.6.5 Taj Pharmaceuticals Latest Developments
...
13 Research Findings and Conclusion
List of Tables
Table 1. Drugs for Schistosomiasis Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Praziquantel
Table 3. Major Players of Oxamniquine
Table 4. Major Players of Other
Table 5. Global Drugs for Schistosomiasis Sales by Type (2016-2021) & (M Units)
Table 6. Global Drugs for Schistosomiasis Sales Market Share by Type (2016-2021)
Table 7. Global Drugs for Schistosomiasis Revenue by Type (2016-2021) & ($ million)
Table 8. Global Drugs for Schistosomiasis Revenue Market Share by Type (2016-2021)
Table 9. Global Drugs for Schistosomiasis Sale Price by Type (2016-2021)
Table 10. Global Drugs for Schistosomiasis Sales by Application (2016-2021) & (M Units)
Table 11. Global Drugs for Schistosomiasis Sales Market Share by Application (2016-2021)
Table 12. Global Drugs for Schistosomiasis Value by Application (2016-2021)
Table 13. Global Drugs for Schistosomiasis Revenue Market Share by Application (2016-2021)
Table 14. Global Drugs for Schistosomiasis Sale Price by Application (2016-2021)
Table 15. Global Drugs for Schistosomiasis Sales by Company (2019-2021) & (M Units)
Table 16. Global Drugs for Schistosomiasis Sales Market Share by Company (2019-2021)
Table 17. Global Drugs for Schistosomiasis Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Drugs for Schistosomiasis Revenue Market Share by Company (2019-2021)
Table 19. Global Drugs for Schistosomiasis Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Drugs for Schistosomiasis Producing Area Distribution and Sales Area
Table 21. Players Drugs for Schistosomiasis Products Offered
Table 22. Drugs for Schistosomiasis Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Drugs for Schistosomiasis Sales by Region (2016-2021) (M Units)
Table 26. Global Drugs for Schistosomiasis Sales Market Share by Region (2016-2021)
Table 27. Global Drugs for Schistosomiasis Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Drugs for Schistosomiasis Revenue Market Share by Region (2016-2021)
Table 29. Americas Drugs for Schistosomiasis Sales by Country (2016-2021) & (M Units)
Table 30. Americas Drugs for Schistosomiasis Sales Market Share by Country (2016-2021)
Table 31. Americas Drugs for Schistosomiasis Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Drugs for Schistosomiasis Revenue Market Share by Country (2016-2021)
Table 33. Americas Drugs for Schistosomiasis Sales by Type (2016-2021) & (M Units)
Table 34. Americas Drugs for Schistosomiasis Sales Market Share by Type (2016-2021)
Table 35. Americas Drugs for Schistosomiasis Sales by Application (2016-2021) & (M Units)
Table 36. Americas Drugs for Schistosomiasis Sales Market Share by Application (2016-2021)
Table 37. APAC Drugs for Schistosomiasis Sales by Region (2016-2021) & (M Units)
Table 38. APAC Drugs for Schistosomiasis Sales Market Share by Region (2016-2021)
Table 39. APAC Drugs for Schistosomiasis Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Drugs for Schistosomiasis Revenue Market Share by Region (2016-2021)
Table 41. APAC Drugs for Schistosomiasis Sales by Type (2016-2021) & (M Units)
Table 42. APAC Drugs for Schistosomiasis Sales Market Share by Type (2016-2021)
Table 43. APAC Drugs for Schistosomiasis Sales by Application (2016-2021) & (M Units)
Table 44. APAC Drugs for Schistosomiasis Sales Market Share by Application (2016-2021)
Table 45. Europe Drugs for Schistosomiasis Sales by Country (2016-2021) & (M Units)
Table 46. Europe Drugs for Schistosomiasis Sales Market Share by Country (2016-2021)
Table 47. Europe Drugs for Schistosomiasis Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Drugs for Schistosomiasis Revenue Market Share by Country (2016-2021)
Table 49. Europe Drugs for Schistosomiasis Sales by Type (2016-2021) & (M Units)
Table 50. Europe Drugs for Schistosomiasis Sales Market Share by Type (2016-2021)
Table 51. Europe Drugs for Schistosomiasis Sales by Application (2016-2021) & (M Units)
Table 52. Europe Drugs for Schistosomiasis Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Drugs for Schistosomiasis Sales by Country (2016-2021) & (M Units)
Table 54. Middle East & Africa Drugs for Schistosomiasis Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Drugs for Schistosomiasis Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Drugs for Schistosomiasis Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Drugs for Schistosomiasis Sales by Type (2016-2021) & (M Units)
Table 58. Middle East & Africa Drugs for Schistosomiasis Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Drugs for Schistosomiasis Sales by Application (2016-2021) & (M Units)
Table 60. Middle East & Africa Drugs for Schistosomiasis Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Drugs for Schistosomiasis
Table 62. Key Application and Potential Industries of Drugs for Schistosomiasis
Table 63. Key Challenges of Drugs for Schistosomiasis
Table 64. Key Trends of Drugs for Schistosomiasis
Table 65. Drugs for Schistosomiasis Distributors List
Table 66. Drugs for Schistosomiasis Customer List
Table 67. Global Drugs for Schistosomiasis Sales Forecast by Region (2021-2026) & (M Units)
Table 68. Global Drugs for Schistosomiasis Consumption Market Forecast by Region
Table 69. Global Drugs for Schistosomiasis Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Drugs for Schistosomiasis Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Drugs for Schistosomiasis Sales Forecast by Country (2021-2026) & (M Units)
Table 72. Americas Drugs for Schistosomiasis Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Drugs for Schistosomiasis Sales Forecast by Region (2021-2026) & (M Units)
Table 74. APAC Drugs for Schistosomiasis Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Drugs for Schistosomiasis Sales Forecast by Country (2021-2026) & (M Units)
Table 76. Europe Drugs for Schistosomiasis Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Drugs for Schistosomiasis Sales Forecast by Country (2021-2026) & (M Units)
Table 78. Middle East & Africa Drugs for Schistosomiasis Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Drugs for Schistosomiasis Sales Forecast by Type (2021-2026) & (M Units)
Table 80. Global Drugs for Schistosomiasis Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Drugs for Schistosomiasis Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Drugs for Schistosomiasis Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Drugs for Schistosomiasis Sales Forecast by Application (2021-2026) & (M Units)
Table 84. Global Drugs for Schistosomiasis Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Drugs for Schistosomiasis Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Drugs for Schistosomiasis Revenue Market Share Forecast by Application (2021-2026)
Table 87. Shin Poong Basic Information, Drugs for Schistosomiasis Manufacturing Base, Sales Area and Its Competitors
Table 88. Shin Poong Drugs for Schistosomiasis Product Offered
Table 89. Shin Poong Drugs for Schistosomiasis Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)
Table 90. Shin Poong Main Business
Table 91. Shin Poong Latest Developments
Table 92. Merck Basic Information, Drugs for Schistosomiasis Manufacturing Base, Sales Area and Its Competitors
Table 93. Merck Drugs for Schistosomiasis Product Offered
Table 94. Merck Drugs for Schistosomiasis Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)
Table 95. Merck Main Business
Table 96. Merck Latest Developments
Table 97. Bayer Basic Information, Drugs for Schistosomiasis Manufacturing Base, Sales Area and Its Competitors
Table 98. Bayer Drugs for Schistosomiasis Product Offered
Table 99. Bayer Drugs for Schistosomiasis Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)
Table 100. Bayer Main Business
Table 101. Bayer Latest Developments
Table 102. EIPICO Basic Information, Drugs for Schistosomiasis Manufacturing Base, Sales Area and Its Competitors
Table 103. EIPICO Drugs for Schistosomiasis Product Offered
Table 104. EIPICO Drugs for Schistosomiasis Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)
Table 105. EIPICO Main Business
Table 106. EIPICO Latest Developments
Table 107. Chandra Bhagat Pharma Basic Information, Drugs for Schistosomiasis Manufacturing Base, Sales Area and Its Competitors
Table 108. Chandra Bhagat Pharma Drugs for Schistosomiasis Product Offered
Table 109. Chandra Bhagat Pharma Drugs for Schistosomiasis Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)
Table 110. Chandra Bhagat Pharma Main Business
Table 111. Chandra Bhagat Pharma Latest Developments
Table 112. Taj Pharmaceuticals Basic Information, Drugs for Schistosomiasis Manufacturing Base, Sales Area and Its Competitors
Table 113. Taj Pharmaceuticals Drugs for Schistosomiasis Product Offered
Table 114. Taj Pharmaceuticals Drugs for Schistosomiasis Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)
Table 115. Taj Pharmaceuticals Main Business
Table 116. Taj Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Drugs for Schistosomiasis
Figure 2. Drugs for Schistosomiasis Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drugs for Schistosomiasis Sales Growth Rate 2016-2026 (M Units)
Figure 7. Global Drugs for Schistosomiasis Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Drugs for Schistosomiasis Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Praziquantel
Figure 10. Product Picture of Oxamniquine
Figure 11. Product Picture of Other
Figure 12. Global Drugs for Schistosomiasis Sales Market Share by Type in 2020
Figure 13. Global Drugs for Schistosomiasis Revenue Market Share by Type (2016-2021)
Figure 14. Drugs for Schistosomiasis Consumed in S. haematobium
Figure 15. Global Drugs for Schistosomiasis Market: S. haematobium (2016-2021) & (M Units)
Figure 16. Drugs for Schistosomiasis Consumed in S. mansoni
Figure 17. Global Drugs for Schistosomiasis Market: S. mansoni (2016-2021) & (M Units)
Figure 18. Drugs for Schistosomiasis Consumed in S. japonicum
Figure 19. Global Drugs for Schistosomiasis Market: S. japonicum (2016-2021) & (M Units)
Figure 20. Drugs for Schistosomiasis Consumed in S. mekongi
Figure 21. Global Drugs for Schistosomiasis Market: S. mekongi (2016-2021) & (M Units)
Figure 22. Drugs for Schistosomiasis Consumed in S. intercalatum
Figure 23. Global Drugs for Schistosomiasis Market: S. intercalatum (2016-2021) & (M Units)
Figure 24. Global Drugs for Schistosomiasis Sales Market Share by Application (2016-2021)
Figure 25. Global Drugs for Schistosomiasis Revenue Market Share by Application in 2020
Figure 26. Drugs for Schistosomiasis Revenue Market by Company in 2020 ($ Million)
Figure 27. Global Drugs for Schistosomiasis Revenue Market Share by Company in 2020
Figure 28. Global Drugs for Schistosomiasis Sales Market Share by Regions (2016-2021)
Figure 29. Global Drugs for Schistosomiasis Revenue Market Share by Region in 2020
Figure 30. Americas Drugs for Schistosomiasis Sales 2016-2021 (M Units)
Figure 31. Americas Drugs for Schistosomiasis Revenue 2016-2021 ($ Millions)
Figure 32. APAC Drugs for Schistosomiasis Sales 2016-2021 (M Units)
Figure 33. APAC Drugs for Schistosomiasis Revenue 2016-2021 ($ Millions)
Figure 34. Europe Drugs for Schistosomiasis Sales 2016-2021 (M Units)
Figure 35. Europe Drugs for Schistosomiasis Revenue 2016-2021 ($ Millions)
Figure 36. Middle East & Africa Drugs for Schistosomiasis Sales 2016-2021 (M Units)
Figure 37. Middle East & Africa Drugs for Schistosomiasis Revenue 2016-2021 ($ Millions)
Figure 38. Americas Drugs for Schistosomiasis Sales Market Share by Country in 2020
Figure 39. Americas Drugs for Schistosomiasis Revenue Market Share by Country in 2020
Figure 40. Americas Drugs for Schistosomiasis Sales Market Share by Type in 2020
Figure 41. Americas Drugs for Schistosomiasis Sales Market Share by Application in 2020
Figure 42. United States Drugs for Schistosomiasis Revenue Growth 2016-2021 ($ Millions)
Figure 43. Canada Drugs for Schistosomiasis Revenue Growth 2016-2021 ($ Millions)
Figure 44. Mexico Drugs for Schistosomiasis Revenue Growth 2016-2021 ($ Millions)
Figure 45. Brazil Drugs for Schistosomiasis Revenue Growth 2016-2021 ($ Millions)
Figure 46. APAC Drugs for Schistosomiasis Sales Market Share by Region in 2020
Figure 47. APAC Drugs for Schistosomiasis Revenue Market Share by Regions in 2020
Figure 48. APAC Drugs for Schistosomiasis Sales Market Share by Type in 2020
Figure 49. APAC Drugs for Schistosomiasis Sales Market Share by Application in 2020
Figure 50. China Drugs for Schistosomiasis Revenue Growth 2016-2021 ($ Millions)
Figure 51. Japan Drugs for Schistosomiasis Revenue Growth 2016-2021 ($ Millions)
Figure 52. Korea Drugs for Schistosomiasis Revenue Growth 2016-2021 ($ Millions)
Figure 53. Southeast Asia Drugs for Schistosomiasis Revenue Growth 2016-2021 ($ Millions)
Figure 54. India Drugs for Schistosomiasis Revenue Growth 2016-2021 ($ Millions)
Figure 55. Australia Drugs for Schistosomiasis Revenue Growth 2016-2021 ($ Millions)
Figure 56. Europe Drugs for Schistosomiasis Sales Market Share by Country in 2020
Figure 57. Europe Drugs for Schistosomiasis Revenue Market Share by Country in 2020
Figure 58. Europe Drugs for Schistosomiasis Sales Market Share by Type in 2020
Figure 59. Europe Drugs for Schistosomiasis Sales Market Share by Application in 2020
Figure 60. Germany Drugs for Schistosomiasis Revenue Growth 2016-2021 ($ Millions)
Figure 61. France Drugs for Schistosomiasis Revenue Growth 2016-2021 ($ Millions)
Figure 62. UK Drugs for Schistosomiasis Revenue Growth 2016-2021 ($ Millions)
Figure 63. Italy Drugs for Schistosomiasis Revenue Growth 2016-2021 ($ Millions)
Figure 64. Russia Drugs for Schistosomiasis Revenue Growth 2016-2021 ($ Millions)
Figure 65. Middle East & Africa Drugs for Schistosomiasis Sales Market Share by Country in 2020
Figure 66. Middle East & Africa Drugs for Schistosomiasis Revenue Market Share by Country in 2020
Figure 67. Middle East & Africa Drugs for Schistosomiasis Sales Market Share by Type in 2020
Figure 68. Middle East & Africa Drugs for Schistosomiasis Sales Market Share by Application in 2020
Figure 69. Egypt Drugs for Schistosomiasis Revenue Growth 2016-2021 ($ Millions)
Figure 70. South Africa Drugs for Schistosomiasis Revenue Growth 2016-2021 ($ Millions)
Figure 71. Israel Drugs for Schistosomiasis Revenue Growth 2016-2021 ($ Millions)
Figure 72. Turkey Drugs for Schistosomiasis Revenue Growth 2016-2021 ($ Millions)
Figure 73. GCC Country Drugs for Schistosomiasis Revenue Growth 2016-2021 ($ Millions)
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
